DrugPatentWatch Database Preview
Details for Patent: 8,338,427
Which drugs does patent 8,338,427 protect, and when does it expire?
This patent has twenty-four patent family members in twenty countries.
Summary for Patent: 8,338,427
Title: | Methods for administering aripiprazole |
Abstract: | The present invention relates, in part, to the discovery that a pharmaceutical composition comprising aripiprazole and a carrier administered in a bolus injection resulted in an extended release profile similar to that obtained by the injection of a poly lactide-co-glycolide microsphere formulation containing the active agent. This surprising result suggests that pharmacologically beneficial extended release formulations without the complexities and expense associated with the manufacture microspheres. |
Inventor(s): | Brown; Josiah (Seattle, WA) |
Assignee: | Alkermes, Inc. (Waltham, MA) |
Application Number: | 12/251,656 |
Patent Claim Types: see list of patent claims | Composition; Use; |
Drugs Protected by US Patent 8,338,427
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-001 | Feb 28, 2013 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | TREATMENT OF SCHIZOPHRENIA | ➤ Try a Free Trial | |||
Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-001 | Feb 28, 2013 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | USE OF ARIPIPRAZOLE IN EXTENDED RELEASE INJECTABLE SUSPENSION IN TREATING ACUTE EPISODES OF SCHIZOPHRENIA | ➤ Try a Free Trial | |||
Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-003 | Sep 29, 2014 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | USE OF ARIPIPRAZOLE IN EXTENDED RELEASE INJECTABLE SUSPENSION IN TREATING ACUTE EPISODES OF SCHIZOPHRENIA | ➤ Try a Free Trial | |||
Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-003 | Sep 29, 2014 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | TREATMENT OF SCHIZOPHRENIA | ➤ Try a Free Trial | |||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 8,338,427
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
8,338,428 | Methods for administering aripiprazole | ➤ Try a Free Trial |
8,759,351 | Methods for administering aripiprazole | ➤ Try a Free Trial |
Patent No. | Title | Estimated Patent Expiration |
International Patents Family Members for US Patent 8,338,427
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 522200 | ➤ Try a Free Trial | |||
Australia | 2004264886 | ➤ Try a Free Trial | |||
Canada | 2534997 | ➤ Try a Free Trial | |||
China | 102133171 | ➤ Try a Free Trial | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |